Hepatocellular carcinoma (HCC) is the typical inflammation-induced neoplasia. It often
prospers where a chronic liver disease persists, thus leading a strong rationale for immune …

Lenvatinib, which is an oral multikinase inhibitor, showed non-inferiority to the sorafenib in
terms of overall survival (OS) and a higher objective response rate (ORR) and better …

Simple Summary The investigation of predictive and prognostic markers is pivotal in patients
affected by hepatocellular carcinoma treated with immune-checkpoint-inhibitors …

The purpose of this article is to evaluate the relationship between the nutrition-based
microenvironment and clinicopathological information for gastric cancer patients and to …

Objectives The Prognostic Nutritional Index (PNI) and Controlling Nutritional Status
(CONUT) score are immunonutritive scoring systems with proven predictive ability in various …

Advanced hepatocellular carcinoma (HCC) is the most frequent liver cancer. Immunotherapy
has been explored in this disease in order to improve survival outcomes. Nowadays …

Simple Summary In oncology, a new era has emerged in the last ten years with the
development of targeted and immune therapies. In hepatocellular carcinoma (HCC), several …

Currently, the relationship between nutritional indices and the prognosis of hepatocellular
carcinoma (HCC) patients treated with immune checkpoint inhibitors (ICIs) and tyrosine …

Introduction: The prognostic nutritional index (PNI) is a multiparametric score introduced by
Onodera based on the blood levels of lymphocytes and albumin in patients with …

Purpose The prognostic nutritional index (PNI) is a common indicator of nutritional and
inflammatory status and is associated with various diseases such as cancer, cardiovascular …